Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,659
Closed -$272K 277
2024
Q2
$272K Sell
3,659
-1,914
-34% -$143K 0.01% 432
2024
Q1
$434K Hold
5,573
0.03% 335
2023
Q4
$397K Sell
5,573
-782
-12% -$54.4K 0.02% 337
2023
Q3
$441K Sell
6,355
-307
-5% -$23.2K 0.02% 339
2023
Q2
$539K Hold
6,662
0.03% 315
2023
Q1
$538K Hold
6,662
0.03% 302
2022
Q4
$498K Hold
6,662
0.03% 328
2022
Q3
$430K Buy
6,662
+1,158
+21% +$80.2K 0.03% 347
2022
Q2
$381K Hold
5,504
0.03% 387
2022
Q1
$423K Hold
5,504
0.03% 409
2021
Q4
$421K Hold
5,504
0.03% 445
2021
Q3
$387K Hold
5,504
0.03% 501
2021
Q2
$367K Hold
5,504
0.02% 527
2021
Q1
$409K Sell
5,504
-520
-9% -$39.5K 0.03% 473
2020
Q4
$439K Hold
6,024
0.03% 411
2020
Q3
$400K Buy
+6,024
New +$381K 0.03% 391

Other funds holding HOLX

Symmetry Partners's HOLX Position: Q3 2024 in Review

Symmetry Partners sold out of Hologic (HOLX) in Q3 2024, closing a stake of 3,659 shares — an estimated $272K sold.

Symmetry Partners first reported a position in HOLX in Q3 2020 and held it in 16 quarters. The position peaked at $539K in Q2 2023. 727 funds tracked by Wall St. Rank hold HOLX as of Q3 2024.

  • Symmetry Partners reported no remaining Hologic position as of Q3 2024 after selling out during the quarter.
  • Symmetry Partners sold 3,659 Hologic shares in Q3 2024, an estimated $272K.
  • Symmetry Partners first reported a position in Hologic in Q3 2020 and held it in 16 quarters.
  • Symmetry Partners's Hologic position peaked at $539K in Q2 2023.
  • 727 funds tracked by Wall St. Rank held Hologic as of Q3 2024.

Based on Symmetry Partners's 13F filing for Q3 2024, filed 29 Oct 2024.